Powder -20℃ 3 years; 4℃ 2 years In solvent -80℃ 6 months;-20℃ 1 month
研究领域：
Cancer
Target：
IC50: 2 nM (TBK1), 6 nM (PDK1)
描述：
BX795 is a potent and selective dual inhibitor of TBK1/PDK1 with IC50 of 2 nM/6 nM, respectively, and has > 50 fold selectivity over PKA, PKC, c-Kit, GSK3β etc.
m.cnreagent.com
